2020 annual financial data
Ultragenyx Pharmaceutical 2020 Operating margin
Direct answer
Operating margin was -121.8%.
Operating income was -330,116,000 USD and net income was -186,566,000 USD.
Operating cash flow was -132,220,000 USD.
Get free Ultragenyx Pharmaceutical email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 271,030,000 USD
- Operating income
- -330,116,000 USD
- Net income
- -186,566,000 USD
- Operating cash flow
- -132,220,000 USD